Trademark: 90189289
Word
ONGENTYS (OPICAPONE) CAPSULES
Status Date
Tuesday, January 18, 2022
Registration Number
6623605
Registration Date
Tuesday, January 18, 2022
Filing Date
Thursday, September 17, 2020
Published for Opposition
Tuesday, March 16, 2021
5 PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM, MOVEMENT DISORDERS, PARKINSON'S DISEASE AND PARKINSONIAN DISORDERS, AND RESTLESS LEGS SYNDROME
Color is not claimed as a feature of the mark.
"(OPICAPONE) CAPSULES"
The mark consists of the stylized wording "ONGENTYS (OPICAPONE) CAPSULES" combined with a design of two curved lines.
ONGENTYS OPICAPONE CAPSULES
Jan 18, 2022
Registered-Principal Register
Dec 17, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 16, 2021
Allowed Principal Register - Sou Accepted
Dec 16, 2021
Statement Of Use Processing Complete
Nov 12, 2021
Use Amendment Filed
Dec 13, 2021
Case Assigned To Intent To Use Paralegal
Nov 12, 2021
Teas Statement Of Use Received
May 11, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 16, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 16, 2021
Published For Opposition
Feb 24, 2021
Notification Of Notice Of Publication E-Mailed
Feb 5, 2021
Approved For Pub - Principal Register
Feb 5, 2021
Examiner's Amendment Entered
Feb 5, 2021
Notification Of Examiners Amendment E-Mailed
Feb 5, 2021
Examiners Amendment E-Mailed
Feb 5, 2021
Examiners Amendment -Written
Feb 1, 2021
Assigned To Examiner
Oct 28, 2020
Notice Of Design Search Code E-Mailed
Oct 27, 2020
New Application Office Supplied Data Entered In Tram
Sep 21, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
